Blepharitis, contact dermatitis, and other symptoms of hypersensitivity may occur. When such symptoms occur, discontinue the use.
Diffuse superficial keratitis, conjunctival injection, irritation, itching, etc. may occur. When such symptoms occur, discontinue the use.
View ADR Monitoring Form